• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Study: Surgeon and anesthesiologist satisfaction an unreliable indicator of patient satisfaction during ocular surgery

Article

According to Boston Medical Center investigators, providers and patients often disagree on what defines adequate sedation and comfort during surgery.

Research from a team of investigators from Boston Medical Center suggests that providers are poor predictors of patient satisfaction with anesthesia and perioperative comfort.

According to the study, investigatorsfound that only a low-level association was demonstrated between a patient and provider’s satisfaction with anesthesia, even when individual measures of patient satisfaction such as pain and anxiety were isolated.

Boston Medical Center (BMC) noted in a news release that conscious anesthesia during ocular surgery is a common practice used to ease pain, discomfort and anxiety. However, there is a varying level of satisfaction among providers and patients about the effectiveness and purpose of anesthesia. Currently, there is no standard for the type or amount of anesthesia administered to a patient, so it is dependent on the setting, patient, and provider to make any judgements.

“If provider assessment is not reflective of patient comfort, patients may not be receiving adequate sedation throughout their procedures,” Hyunjoo Lee, MD, PhD, an ophthalmologist at Boston Medical Center, noted in the news release. “This could lead to lower patient satisfaction.”

The BMC news release noted that patient satisfaction is considered to be difficult to assess intraoperatively, as patients are completely draped and communication is somewhat limited. Surrogate measures including movement and increased heart rate, in addition to patients reporting pain and anxiety, are often used clinically to determine the appropriate level of sedation during ocular surgery.

However, investigators also pointed out that there is no evidence showing that these measures accurately predict patient satisfaction. Provider judgment and satisfaction with anesthesia intraoperatively often determines the initial dose of sedation, as well as the need for additional anesthesia throughout the procedure.

“This poor correlation may suggest differing expectations pertaining to quality care,” Lee, also an assistant professor of ophthalmology at Boston University School of Medicine, noted in the news release. “For instance, surgeons may value a quiet patient with minimal eye movement during surgery, whereas a patient may value being pain-free or a complete lack of awareness of the surgery. Alternatively, an overly sedated patient might exhibit excessive eye movement, lowering surgeon satisfaction, or unstable vital signs, lowering anesthesia provider satisfaction. Ultimately, the goal should be to maximize patient satisfaction without compromising patient safety.”

According to BMC, investigators analyzed 283 ophthalmic surgical cases with patients whom speak English, Spanish or Haitian Creole. The patients were sedated with benzodiazepine prior to the start of surgery and then were given supplemental anesthesia throughout the surgery, as needed. After surgery, the patients, surgeons and anesthesiologist were all given surveys to assess their level of satisfaction. The correlation of patient to surgeon satisfaction was 0.333 on a scale of 0 to 1, indicating a moderately weak correlation.

BMC noted in its release that investigators recommend that future research focus on better understanding patient satisfaction with anesthesia during ocular surgery.

The news release noted that funding for this study was in part supported by the Boston University Clinical and Translational Science Institute, grant number 1UL1-TR001430.

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
Dr. Inder Paul Singh's Insights: Improving Glaucoma Outcomes with Early Intervention and Reduced Medication
CIME 2024: Kelsey Roelofs, MD, details collaborative strategies for the management of thyroid eye disease
CIME 2024: Diagnostic tips and treatments for managing Demodex blepharitis
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
© 2024 MJH Life Sciences

All rights reserved.